应用普通肝素钠治疗进展性脑卒中的疗效观察  

作　　者：刘丽波[1] 宋志彬[1] 

机构地区：[1]南方医科大学附属小榄人民医院,广东中山528415

出　　处：《中国社区医师（医学专业）》2011年第25期43-44,共2页

摘　　要：目的:探讨肝素治疗进展性脑卒中的合理的个体治疗方案。方法:71例患者分两组,治疗组(普通肝素组,神经功能评分≥25分),对照组(低分子肝素组,神经功能评分对照组≤24分),对两组治疗前后SSS评分及凝血时间进行对照观察,评分及凝血时间采用独立样本t检验。结果:治疗组患者2～3天后神经功能评分明显优于对照组,7天后无显著性差异。结论:进展性脑卒中发病后6～48小时,进展较快推荐静脉滴注普通肝素。Objective：To research the best individual treatment plan for progressive stroke. Method ： 71 patients were divided into two groups, treatment group （ common hepafin, SSS ≥ 25 ） , control group （ low molecular heparin, SSS ≤ 24 ） and the SSS and CT were compared before and after treatment, SSS and CT were dealt with independent t example test. Result ： SSS of treatment group is better than control group after treatment from first to third day, there. Conclusion：Intravenous drip of heparin sodium is recommended for those status progress rapidly after progressive stroke attack from 6 to 48 hours.

关 键 词：肝素 治疗 进展性脑卒中 

分 类 号：R743.3[医药卫生—神经病学与精神病学]